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The number of hepatectomies has increased greatly in recent years. Surgery for hepatocellular
carcinoma (HCC) in the normal liver has not increased. However, the increase in numbers of
hepatectomies for HCC associated with liver cirrhosis is remarkable. More than 80% of our hepatec-
tomy cases were cirrhotic and about 80% of these cirrhotic cases had HCCs 5cm or less in diameter. The
operative mortality rate has improved in the latter half of this series, from 10.1% (9/89) to 1.5% (5/338),
in spite of an increase in cases with poor liver function. This corresponds to a decrease in the mean value
of the annual operative blood loss. The survival rates after hepatectomy for all cases (n 378) were
40.6% + 6.6 (% + SE) for, 5 year and 22.7% + 5.3 for 10 year at the end of 1988. A difference of the
5-year survival rate between the patients operated on before 1981 (n 78, 25.6% + 4.9) and after 1982
(n= 300, 46.1% + 4.8) was observed (p<0.05). Because the cancer-free survival rates of the patients
operated on in the two periods, before 1981 and after 1982, were almost the same, the recent
improvement of the survival rates seems to be due to a prolongation of survival time after recurrence.
KEY WORDS: Hepatocellular carcinoma, hepatectomy, operative mortality rate, survival rate,
cancer-free survival
INTRODUCTION
From the middle of the 1970s, hepatectomy for hepatocellular carcinoma (HCC)
has been the routine clinical practice. Although the numbers of hepatectomies
during the 1970s were not many, recently the numbers have increased remarkably.
Modern technology has provide some weapons in the field of medicine such as
ultrasonography(US) computerized tomography (CT) and some new surgical
instruments. These new techniques have allowed the early detection ofHCC. Many
operable cases of HCC were detected during a follow-up survey for chronic liver
diseases. The effects of these changes seems to occur after 1981. This paper reports
the results of hepatectomy for HCC with special reference to the annual trends in
hepatic oncology.
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PATIENTS AND METHODS
The subject of this report is 427 patients with HCC treated by hepatectomy
between October, 1974 and December, 1988 at the National Cancer Center
Hospital. In the analysis of survival, cases of non-curative resection or re-resection
are excluded. A non-curative resection is defined here as a resection in which some
macroscopic tumor or tumor demonstrated by imaging is not removed at laparo-
tomy. Eleven cases of the mixed-type of hepatocellular and cholangiocellular liver
cancer are included in this series.
RESULTS
Number of Hepatectomies
Until the end of 1988, a total of 664 hepatectomies were completed including 427
HCC and 237 liver tumors of other kinds as shown in Table 1. HCC with liver
cirrhosis (LC) constituted more than half of the cases, and the second largest group
was liver metastases including about 30 cases from a non-splanchnic origin. HCC
without LC was only 11% (73/664) of the cases. There were some other kinds of
liver tumors in this series, such as children’s liver tumors (23), benign liver tumors
(36), Klatskin tumors (26), cholangiocellular carcinomas (8), gall bladder cancers
(11) and one other rare liver maalignancy (sclerosing epithelioid hemangiosar-
coma). The annual number of hepatectomies at our hospital, for all hepatic
diseases is shown in Figure 1. Cases are divided into three categories, HCC in the
normal liver [HCC,LC(-)], HCC with liver cirrhosis [HCC, LC(+ )] and other
liver tumors. "Cirrhosis" here means "injured liver" which includes not only true
cirrhosis, but also precirrhosis and chronic active hepatitis.
Size and number ofHCC nodules
Trends in the size of HCC nodules treated by hepatectomy each year are
demonstrated in Figure 2. The greatest dimension of the biggest tumor in each case
Table 1 Number of hepatectomy for various kinds of hepatic disease
Liver Tumor No. of Cases (%)b)
Hepatocellular carcinoma, with cirrhosis
Hepatocellular carcinoma, without cirrhosis
Liver metastases
Benign tumor
Klatskin tumor
Children’s liver malignancy
Gall bladder cancer
Cholangiocellular carcinoma
other a)
Total
a) Sclerosing epithelioid hemangiosarcoma
b) Cases operated on before the end of 1988.
354 (53.3%)
73 (11.0%)
132 (19.9%)
36 (5.4%)
26 (3.9%)
23 (3.5%)
11 (1.7%)
8(1.2%)
(0.2%)
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Figure 1 Annual trends in the number of hepatectomies carried out at the National Cancer Center
hospital. HCC, LC(-) means Hepatocellular carcinoma in the normal liver and HCC, LC( + means
that associated with liver cirrhosis, precirrhosis or chronic active hepatitis. Other tumors includes other
kinds of malignancies or benign tumors listed in Table 1.
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Figure 2 The numbers of hepatectomized cases in each year are shown divided according to the largest
diameter of the largest deposit of HCC(s) in each case.238 S. YAMASAKI ET AL.
represents the "size" of the case. The sizes of the groups are as follow: (1)2cm or
less, (2)>2cm and -<5cm, (3)> 5cm and -< 10cm and (4)more than 10cm. The
numbers in the larger size groups, (3) and (4), are almost stable for the whole
period of this series. However, those of the smaller, (1) and (2), have been
increasing year by year recently. The proportions of the number ofHCC nodule(s),
solitary or multiple, in these four size groups and in overall cases were almost the
same. Thus, the solitary cases were 215 and the multiples were 212, as shown in
Figure 3.
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Figure 3 The numbers of cases with HCC(s) in each size group by solitary or multiple nodules. The total
number of cases with solitary nodule was 215/427 (50.4%) and that of multiple nodules was 212/427
(49.6%).
Liver function
There have been several classifications of liver function, such as that of Child1. But
these classifications of liver function involve all patients with liver diseases from
those with almost normal liver function to those in the end stage of the disease.
Generally, the patients in whom hepatectomy is indicated have rather good liver
function. Child’s A or at worst the better part of Child’s B. Surgeons, want a
classification which categorize patients with good liver function to help in deciding
on indications for operation and selection of surgical procedure. Patients, are
divided into three functional groups, A, B, and C by the value of total serum
bilirubin (T. Bil.) and that of Indocyaningreen (ICG) 15 minutes retention rate
[ICG(15’)], "Function A" is with 1.0mg/dl or less for T. Bil. and 15% or less for
ICG(15’). "Function B" is with "T. Bil. > 1 and -<2.0mg/dl and ICG(15’) -<40%"
and "function C" is with <T. Bil. > 2mg/dl or ICG(15’) >40% as shown in Figure
4.RESULTS OF HEPATECTOMY FOR HEPATOMA 239
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Figure 4 A classification of liver function by total serum bilirubin and Indocyanin-green (ICG) 15
minutes retention rate. "Function A"’. almost normal function, "Function B": moderately disturbed
function, "Function C": highly disturbed function.
Figure 5 demonstrates the annual change in liver function of hepatectomized
patients. The number of hepatectomies is shown by three groups of liver function;
"function A" (almost normal), "function B" (moderately disturbed) and "function
C" (highly disturbed). In Figure 5, there is an increase in cases with "function B".
The total numbers of hepatectomized cases in these functional groups were 141
(33.0%, 226 (52.9%) and 60 (14.1%), for "function A", "B" and "C", respectively.
Surgical Procedure
The surgical procedures adopted in this series classified as non-anatomical resec-
tion, sub-segmentectomy, mono-segmentectomy, bi-segmentectomy and tri-
segmentectomy. The hepatic "segments" are those defined by Healey
2 as the right
posterior, the right anterior, the left medial and the left lateral segment. "Sub-
segmentectomy" is defined as an anatomical resection smaller than one hepatic
segment3. "Non-anatomical" resection is, in general, a small resection. However,
the difference between "non-anatomical’ and "sub-segmentectomy" is whether or
not it is anatomical. The numbers of these surgical procedures are shown in Table
2. The annual change in the surgical procedures are shown in Figure 6. The increase
of the number of small range resection such as non-anatomical resection and
subsegmentectomy is remarkable, although the number of mono-segmentectomy240 S. YAMASAKI ET AL.
and bi-segmentectomy increased a little with a rise with the total number of
resections.
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Figure 5 The annual trend of liver function in the hepatectomy cases. The definition of liver function, A,
B, and C, are shown in the Figure 4.
Table 2 Surgical procedures for HCCS
Surgical Procedures No. of Cases (%)
Non-anatomical resection 197 (46.1%)
Sub-segmentectomy 101 (23.7%)
Mono-segmentectomy 44 (10.3%)
right posterior 21
right anterior 7
left medial
left lateral 15
Bi-segmentectomy 62 (14.5%)
right 31
left 17
central 14
Tri-segmentectomy 23 (5.4%)
right 19
left 4
Total 427RESULTS OF HEPATECTOMY FOR HEPATOMA 241
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Figure (i The numbers of surgical procedures in each period.
Operative Mortality Rate
The overall mortality rate was 3.3% (14/427) between 1974 and 1988 (Figure 7).
The period was divided into two halves, the earlier half, 1974-1981, and the latter,
1982-1988. The mortality rate in the earlier stage was 10.1% (9/89) and that in the
latter was 1.5% (5/338). This difference was significant (p< 0.0,1).
Survival Rate After Hepatectomy
The postoperative survival rate was calculated at the end of 1988 by the
Kaplana-Mier method. The cases of operative mortality (deaths within 30 post-
operative days) were included. However, cases of non-curative resection and cases
of re-resection were excluded. There were 50 survivors longer than 5 years and 6
out of 50 are presently surviving more than 10 years, (May, 1989).
Overall cases
The overall survival rates (mean % _+ SD) in 378 patients including operative
mortalities and excluding palliative resections and re-resections, were 82.9% + 2.0,
69.5% + 2.6, 57.0% _+ 3.1, 45.0% + 3.5, 40.6% _+ 3.7, 28.9% _+ 4.4 and 22.7% _+ 5.3
for 1, 2, 3, 4, 5, 7, and 10 year, respectively (Figure 8).242 S. YAMASAKI ET AL.
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Figure 7 The operative rates (within 30 postoperative days) in hepatectomy for HCC. The differences of
the mortality rate between 1974-1981 and 1982-1988 are significantly (p<0.01). The number above
each column is the number of death(s) in each year.
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Figure $ The survival curve for cases overall after hepatectomy. The cases of operative mortality are
included and those of non-curative resections and reresections are excluded. The definition of "non-
curative resection" is described in the text.RESULTS OF HEPATECTOMY FOR HEPATOMA 243
Survival rate by cirrhotic or non-cirrhotic
The survival rates of the cirrhotic patients(n 315) and the non-cirrhotic (n =63)
were calculated separately (Figure 9). Although the shapes of the survival curves of
these two groups are different, the 5 year survival rates were the same.
Survival
Rate (%)
I0(
Cirrhotic vs. Non-cirrhotic
Non-cirrhotic (n=63)
L___/___J l_l._J
Cirrhotic (n=315)
0
5 I0 15 Year
Figure 9 A comparison of survival rate between the non-cirrhotic and cirrhotic patients. During 1-432
days, the survival rate of the cirrhotic group was good however during 3888-4320 days the survival rate
of the non-cirrhotic group was better (p< 0.05).
Difference in survival by year of operation
The difference in the survival rate between the patients operated on before 1981
(n 78) and after 1982 (n 300) has been discussed (Figure 10). Three, 5, and 10
year survival rates of the patients operated on before 1981 were 37.2% +5.5,
25.6% + 4.9 and 16.1% +_ 4.6, respectively. Those of the patients after 1982 were
63.2% + 3.6 for 3 years and 46.1% + 4.8 for 5 years. The difference was significant
at 1-5 years(p< 0.05).
DISCUSSION
The number of hepatectomies in recent years has been increasing greatly. Surgery
for HCC in the normal liver have not increased. However, the increase in
hepatectomy rate for HCC associated with liver cirrhosis is remarkable. The244 S. YAMASAKI ET AL.
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Figure 10 T,he differences in the survival rate between the patients operated on before 1981 and that
after 1982. During 1-1904 days, the difference was significant (1-952) days: p<0.001,953-1666 days:
p<0.01, 1667-1904 days: p<0.05).
concept, that chronic liver disease, such as chronic hepatitis or cirrhosis is an
important aspect in the management ofHCC, is well established throughout Japan.
Fortunately, at the same time, modern technology provided some powerful tools
which can rationalize the concept. Around 1980, US and CT were introduced into
clinical medicine. Surgeons were made aware of an increase in the number of
operable cases with HCCs, especially HCCs of small size (Figure 1). Since 1982, the
number of hepatectomies for HCC with LC has been increasing. The increase in
numbers of small HCC less than 5cm in diameter after 1982 is outstanding (Figure
2). And at the same time, these modern diagnostic techniques picked up the second
or third foci in the same liver. The incidence of cases with small multiple nodules
was the same as those with larger HCCs (Figure 3).
Small HCCs are detected during screening for chronic liver disease. Almost all
small HCCs are detected in the injured liver. It is now routine to tackle hepatec-
tomy in patients with disturbed liver function. As summarized in Figure 4, more
than 80% of our hepatectomy cases were cirrhotic and about 80% of these cirrhotic
cases had HCCs 5cm or less in diameter. Thus, 2/3 of our cases were small HCCs in
cirrhosis. However, with the advancement in surgical technique, mainly saving in
blood loss (Figure 11), the indications for hepatectomy in the injured liver have
been expanded. The number of operations in the injured liver are increasing yearly
as depicted in Figure 5. The increase in small HCCs in the injured liver is associated
with a change in the surgical procedures carried out. During 1970s, more than half
of our hepatectomies were extended resections such as bi- or tri-segmentectomy
(Figure 6), in recent years the numbers of non-anatomical resection and subseg-
mentectomy have increased.RESULTS OF HEPATECTOMY FOR HEPATOMA 245
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Figure 11 The volume of blood loss in hepatectomy. The difference of the mean value from 1974 to 1981
was significantly more than the latter years (p< 0.05).
The operative mortality rate has improved in the latter half of this series, in spite
of the increase of cases with poor liver function. This also corresponds to the
decrease of the mean value of operative blood loss per annum (Figure 11). We
adopted the vascular clamping technique around 1981. At the time of parenchymal
transection, the hepatic artery and the portal vein at the porta hepatis were
clamped. This procedure effectively decreases blood loss. In the cirrhotic patients,
the mean value of blood loss among who survived surgery (n 345) was 1394.7 +
159.7ml (mean + SD). On the other hand, those who died within 30 postoperative
days (n =9), had a blood loss of 3529.4m1+ 1954.2. This difference was signifi-
cant(p< 0.01, two tailed t-test).
The survival rates after hepatectomy overall were 40.6% for 5 year and 22.7%
for 10 year at the end of 1988.
The influence of combined chronic disease on survival was examined. Some
surgeons have reported the results of hepatectomy comparing cirrhotic and non-
cirrhotic patients. However, the conclusion is still controversial4-8. The survival
rates were calculated in the non-cirrhotic group (n 63) and in the cirrhotic group
(n 315) separately (Figure 9). The 5 year survival rates were the same (39.3% vs.
39.9%) between the two groups. However, the shapes of the survival curves are
somewhat different. The curve of the non-cirrhotic group levelled out around 4 or 5
years and there was no death after 5 years. This is a common pattern for the
survival curve in many other visceral cancers. This may suggest that the prognosis
of the non-cirrhotic patients depends solely upon the status of the primary cancer,
on the contrary, the curve of the cirrhotic patients continues to go down to around246 S. YAMASAKI ET AL.
10 years. This is peculiar to the disease, HCC with cirrhosis. Thus, it may suggest
that the destiny of the patients depend not only upon the status of the primary
cancer but also upon other factors, such as liver function and multiple genesis of
HCC in cirrhosis.
The survivals were compared between the earlier half (1974-1981) of this series
and the latter half (1982-1988). As shown in figure 10, the result of the latter half
(n=300) was clearly better. Before concluding that "these data suggest the
treatment of HCC has improved recently", the background of the patients of each
period should also be compared. The cases were divided by theTNM stage
9 (Figure
12). In the group of patients operated on before 1981, there was no case of stage 1
and the numbers in other three stages, stage 2, 3 and 4, were almost even. In the
latter group, operated on after 1982, the number of cases in stage 3 has increased.
However, the proportion of stage 1 and 2 after 1982 has increased significantly.
There were more cases of an early stage of cancer in the latter half, but from the
point of view of liver function (Figure 13), there were more cases with injured liver
function in the latter half. The author feels that the survival rates should be
compared between cases in a same stage of the cancer and with the same liver
function. Figure 14 shows a comparison of the survival rates between the cases with
HCC 5cm or less in diameter and in function B, operated on before 1981 and after
1982. The differences between the two survival curves are significant by the
generalized Wilcoxon test (p< 0.001). Here, it can be said that the recent improve-
ment of the survival rate in the patients is due not only to "early detection" but also
to "progress of treatment".
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Figure 12 The number of cases by the TNM classification of liver cancer (UICC) in the earlier and latter
period of this series. There was no case of Stage in the earlier period.RESULTS OF HEPATECTOMY FOR HEPATOMA 247
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Figure 13 The change in the number of cases by liver function as defined in igure 4. During 1974-1981
the numbers of "Function A", "B" and "C" were 34, 35 and 9 and during 1982-1988 88, 166 and 47,
respectively.
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Figure 14 The survival rates of patients with HCC 5cm or less in "Function B". The difference between
the group operated on before 1981 and that after 1.982 was significant by the generalized Wilcoxon test
(p<0.001).248 S. YAMASAKI ET AL.
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Figure 15 The cancer-free survival rates after hepatectomy of the patients operated on before 1981 and
after 1982. The cases of operative mortality, hospital death, death from non-HCC, active double cancers
in other organs and insufficient follow-up were excluded. There was no significant difference.
To verify "progress of treatment", some other analyses were added. In Figure 15,
the cancer-free survival rates of the earlier and the recent group are shown. The
cancer-free survival rates of these two groups were almost the same, although in the
recent group, there were more cases with HCCs of the earlier stages as shown in
Figure 12. This may suggest that the small range resections such as non-anatomical
resection and subsegmentectomy for the small HCCs in the injured liver which
were carried out in the recent group were not sufficiently radical. At the same time,
this may suggest a higher than expected incidence of multicentric carcinigenesis of
HCC in the injured liver. In Figure 16, the survival after the detection of recurrence
is compared between the two groups, the early and the recent stage. In this analysis
of the survival rates, the cases of operative mortalities, hospital deaths, deaths of
non-HCC, active double cancers of other organs and insufficient follow-up were
excluded. Howeve although the cancer-free survival rates were the same, the
survival rates were different, which means in the recent group the cancer-bearing
survival term has been prolonged. This shows the treatment for recurrences in
recent years is more effective than in the earlier stage. In the earlier stage of this
series, re-resection was the only effective treatment for recurrence, but recently not
only re-resection but arterial embolization and ethanol injection therapy have been
adopted. The possibility that, in the recent group, early detection of a recurrent
lesion may be associated with an apparent longer survival may not be neglected.
The prolongation of the survival in the recent cases must be a fruit of these multiple
factors.RESULTS OF HEPATECTOMY FOR HEPATOMA 249
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Eigure 16 A comparison of the suival rate and the cancer-free suival rate in the cases operated on
before 1981 (left) and in those after 1982 (right). The subjects of these analyses were the same as those
in the Figure 15.
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